Number of items: 5.
Nock, S.
(2021)
The dual kinase and scaffold function of Btk downstream
of GPVI and CLEC-2 in platelets.
PhD thesis, University of Reading.
doi: https://doi.org/10.48683/1926.00101688
Holbrook, L.-M., Keeton, S. J., Sasikumar, P., Nock, S., Gelzinis, J., Brunt, E., Ryan, S., Pantos, M. M., Verbetsky, C. A., Gibbins, J. M.
ORCID: https://orcid.org/0000-0002-0372-5352 and Kennedy, D. R.
(2021)
Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.
British Journal of Pharmacology, 178 (3).
pp. 550-563.
ISSN 1476-5381
doi: https://doi.org/10.1111/bph.15291
Nicolson, P. L., Nock, S. H., Hinds, J., Garcia-Quintanilla, L., Smith, C. W., Campos, J., Brill, A., Pike, J. A., Khan, A. O., Poulter, N. S., Kavanagh, D. M., Watson, S., Watson, C. N., Clifford, H., Huissoon, A. P., Pollitt, A. Y., Eble, J. A., Pratt, G., Watson, S. P. and Hughes, C. E.
(2020)
Low dose Btk inhibitors selectively block platelet activation by CLEC-2.
Haematologica, 105 (1).
ISSN 1592-8721
doi: https://doi.org/10.3324/haematol.2019.218545
Nicolson, P. L. R., Hughes, C. E., Watson, S., Nock, S. H., Hardy, A. T., Watson, C. N., Montague, S. J., Clifford, H., Huissoon, A. P., Malcor, J.-D., Thomas, M. R., Pollitt, A. Y., Tomlinson, M. G., Pratt, G. and Watson, S. P.
(2018)
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation to GPVI.
Haematologica, 103 (12).
pp. 2097-2108.
ISSN 1592-8721
doi: https://doi.org/10.3324/haematol.2018.193391
Bye, A. P., Unsworth, A. J., Desborough, M. J., Hildyard, C. A. T., Appleby, N., Bruce, D., Kriek, N., Nock, S. H., Sage, T., Hughes, C. E. and Gibbins, J. M.
(2017)
Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib.
Blood Advances, 1 (26).
pp. 2610-2623.
ISSN 2473-9529
doi: https://doi.org/10.1182/bloodadvances.2017011999
This list was generated on Fri Jan 27 01:03:15 2023 UTC.